Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 1,440,000 shares, an increase of 5.9% from the July 15th total of 1,360,000 shares. Based on an average daily volume of 239,600 shares, […]
Enanta Pharmaceuticals, Inc. Expected to Post Q2 2024 Earnings of ($2.61) Per Share (NASDAQ:ENTA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tang Capital Management LLC raised its holdings in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 45.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the biotechnology company’s stock after purchasing an additional 62,300 shares during the […]
StockNews.com initiated coverage on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Get Rating) in a research note published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Several other research firms have also recently commented on ENTA. JPMorgan Chase & Co. cut their price target on Enanta Pharmaceuticals from $74.00 to $60.00 […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Rating) had its target price reduced by research analysts at HC Wainwright from $68.00 to $48.00 in a report released on Tuesday, The Fly reports. HC Wainwright’s price objective points to a potential upside of 81.06% from the stock’s current price. Several other analysts also recently weighed in on the […]